Hepion Pharmaceuticals (HEPA) Earnings Date & Reports

Hepion Pharmaceuticals Inc is a biopharmaceutical company that focuses primarily on the development of drug therapy for the treatment of chronic liver diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

HEPA is expected to report earnings to fall 73.90% to -290 cents per share on May 16

Hepion Pharmaceuticals HEPA Stock Earnings Reports

Q1'23

Est.

$-2.90

Q4'24

Missed

by $9.14

Q4'22

Missed

by $1.68

Q3'22

Beat

by $0.06

Q2'22

Missed

by $4.94

The last earnings report on April 08 showed earnings per share of -1110 cents, missing the estimate of -197 cents. With 163.12K shares outstanding, the current market capitalization sits at 3.18M.

View a ticker or compare two or three

Compare

HEPA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For HEPA
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

399 Thornall Street

Phone

+1 732 902-4000

Employees

Web

https://www.hepionpharma.com